XML 55 R45.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK OPTIONS (Tables)
9 Months Ended
Mar. 31, 2017
Fair value weighted average assumptions
   

      Nine Months Ended

March 31,

 
    2017        2016  
Expected volatility   47.29% to 104.94%     60.41% to 104.94%  
Risk-free interest rate   0.30% to 1.05%     0.30% to 1.05%  
Expected life (years)     2.50 – 3.25       2.50 – 3.25  
Company's non-vested employee stock options

A summary of the status of the Company’s non-vested employee stock options during the nine months ended March 31, 2017 is presented below: 

 

    Options    

Weighted Average Grant-Date

Fair Value

 
             
Non-vested at July 1, 2016     38,750     $ 3.22  
Granted     37,500       4.14  
Vested     (28,125 )     3.19  
Forfeited     -       -  
Non-vested at March 31, 2017     48,125     $ 3.77  
                 

 

A summary of the status of the Company’s non-vested employee stock options during the nine months ended March 31, 2016 is presented below: 

 

    Options    

Weighted Average Grant-Date

Fair Value

 
             
Non-vested at July 1, 2015     17,500     $ 1.69  
Granted     40,000       3.26  
Vested     (18,750 )     (3.26
Forfeited     -       -  
Non-vested at March 31, 2016     38,750     $ 3.20  
                 

 

2007 Employee Plan [Member]  
Option activities

A summary of option activities under the 2007 Employee Plan during the Nine-month period ended March 31, 2017 is presented as follows:

 

    Options    

Weighted Average

Exercise

Price

   

Weighted Average Remaining

Contractual

Term (Years)

   

Aggregate

Intrinsic

Value

 
                         
Outstanding at July 1, 2016     90,000     $ 3.26       3.42     $ 30  
Granted     37,500       4.14       5.00       -  
Exercised     -       -       -       -  
Forfeited or expired     -       -       -       -  
Outstanding at March 31, 2017     127,500     $ 3.52       3.35     $ 79  
Exercisable at March 31, 2017     79,375     $ 3.36       2.61     $ 62  

 

A summary of option activities under the 2007 Employee Plan during the Nine-month period ended March 31, 2016 is presented as follows:

 

    Options    

Weighted Average

Exercise

Price

   

Weighted Average Remaining

Contractual

Term (Years)

   

Aggregate

Intrinsic

Value

 
                         
Outstanding at July 1, 2015     130,000     $ 3.93       1.57     $ -  
Granted     40,000       3.26       4.97       4  
Exercised     -       -       -       -  
Forfeited or expired     (80,000 )     4.35       -       -  
Outstanding at March 31, 2016     90,000     $ 3.26       3.67     $ -  
Exercisable at March 31, 2016     51,250     $ 3.28       3.07     $ -  

 

2007 Directors Equity Incentive Plan [Member]  
Option activities

A summary of option activities under the 2007 Directors Plan during the nine months ended March 31, 2017 is presented as follows: 

 

    Options    

Weighted Average

Exercise

Price

   

Weighted Average Remaining

Contractual

Term (Years)

   

Aggregate

Intrinsic

Value

 
                         
Outstanding at July 1, 2016     415,000     $ 3.14       3.29     $ 198  
Granted     50,000       4.14       5.00       -  
Exercised     -       -       -       -  
Forfeited or expired     (50,000 )     2.30       -       -  
Outstanding at March 31, 2017     415,000     $ 3.36       3.18     $ 325  
Exercisable at March 31, 2017     415,000     $ 3.36       3.18     $ 325  

 

A summary of option activities under the 2007 Directors Plan during the nine months ended March 31, 2016 is presented as follows: 

 

    Options    

Weighted Average

Exercise

Price

   

Weighted Average Remaining

Contractual

Term (Years)

   

Aggregate

Intrinsic

Value

 
                         
Outstanding at July 1, 2015     365,000     $ 3.65       1.99     $ 53  
Granted     200,000       3.12       3.54       -  
Exercised     -       -       -       -  
Forfeited or expired     (150,000 )     (4.35 )     -       -  
Outstanding at March 31, 2016     415,000       3.14       4.97       91  
Exercisable at March 31, 2016     415,000       3.14       4.97       91